ARTICLE | Company News
Biovail receives FDA approval
September 28, 2000 7:00 AM UTC
The FDA granted final marketing approval for BVF's generic version of Procardia XL nifedipine, which is marketed by Pfizer (PFE, New York, N.Y.) to treat hypertension and angina. Partner Teva (TEVA) w...